These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 11032912
21. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status. Quist SR, Wang-Gohrke S, Köhler T, Kreienberg R, Runnebaum IB. Cancer Gene Ther; 2004 Aug; 11(8):547-54. PubMed ID: 15153938 [Abstract] [Full Text] [Related]
22. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR. Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637 [Abstract] [Full Text] [Related]
23. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models. Nielsen LL, Gurnani M, Syed J, Dell J, Hartman B, Cartwright M, Johnson RC. Hum Gene Ther; 1998 Mar 20; 9(5):681-94. PubMed ID: 9551616 [Abstract] [Full Text] [Related]
26. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. Clin Cancer Res; 2001 Jun 20; 7(6):1765-72. PubMed ID: 11410518 [Abstract] [Full Text] [Related]
28. Doxycycline potentiates antitumor effect of cyclophosphamide in mice. Chhipa RR, Singh S, Surve SV, Vijayakumar MV, Bhat MK. Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):268-77. PubMed ID: 15667832 [Abstract] [Full Text] [Related]
29. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors. Raja Gabaglia C, Diaz de Durana Y, Graham FL, Gauldie J, Sercarz EE, Braciak TA. Cancer Res; 2007 Mar 01; 67(5):2290-7. PubMed ID: 17332360 [Abstract] [Full Text] [Related]
30. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors). Hirokawa Y, Levitzki A, Lessene G, Baell J, Xiao Y, Zhu H, Maruta H. Cancer Lett; 2007 Jan 08; 245(1-2):242-51. PubMed ID: 16540233 [Abstract] [Full Text] [Related]
31. Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells. Irie A, Matsumoto K, Anderegg B, Kuruma H, Kashani-Sabet M, Scanlon KJ, Uchida T, Baba S. Cancer Gene Ther; 2006 Mar 08; 13(3):298-305. PubMed ID: 16110311 [Abstract] [Full Text] [Related]
36. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo. Shi B, Yaremko B, Hajian G, Terracina G, Bishop WR, Liu M, Nielsen LL. Cancer Chemother Pharmacol; 2000 Mar 08; 46(5):387-93. PubMed ID: 11127943 [Abstract] [Full Text] [Related]
37. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. Collinet P, Vereecque R, Sabban F, Vinatier D, Leblanc E, Narducci F, Querleu D, Quesnel B. J Obstet Gynaecol Res; 2006 Oct 08; 32(5):449-53. PubMed ID: 16984510 [Abstract] [Full Text] [Related]
38. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer. Liao Y, Zou YY, Xia WY, Hung MC. Cancer Gene Ther; 2004 Sep 08; 11(9):594-602. PubMed ID: 15272313 [Abstract] [Full Text] [Related]
39. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models. Kojima Y, Honda K, Hamada H, Kobayashi N. J Surg Res; 2009 Nov 08; 157(1):e63-70. PubMed ID: 19345377 [Abstract] [Full Text] [Related]
40. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models. Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC. Int J Oncol; 2004 May 08; 24(5):1181-8. PubMed ID: 15067340 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]